Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV003390885 | SCV004119734 | pathogenic | ZEB2-related disorder | 2022-11-30 | criteria provided, single submitter | clinical testing | The ZEB2 c.1257delG variant is predicted to result in a frameshift and premature protein termination (p.Gly421Glufs*6). This variant was reported in an individual with a clinical suspicion of Mowat-Wilson syndrome (Saunders et al 2009. PubMed ID: 19842203). This variant has not been reported in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. Frameshift variants in ZEB2 are expected to be pathogenic. This variant is interpreted as pathogenic. |
Molecular Genetics Laboratory, |
RCV000169696 | SCV000221232 | pathogenic | Mowat-Wilson syndrome | 2015-03-02 | no assertion criteria provided | clinical testing |